GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Year: 2014
Type: article
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Gilead Sciences, Tufts Medical Center
OpenAlex ID: W2086570276
